After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out about its atopic dermatitis treatment Ebglyss. Ebglyss is a once-monthly ...

David Chang drove almost 80 miles to an auto-body shop in Tampa after slamming into a 13-year-old girl bicycling home from Pine View School in 2022, leaving her lying in the roadway. His vision ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound, opening up a new direct-to-consumer (DTC) channel that could shake up how the ...

Volatile action in February rattled tech titans like Tesla, Nvidia and Palantir Technologies, leading to a changing of the guard on IBD Leaderboard. While Tesla, Palantir and Nvidia have been ...

The leaked text chain with Trump officials discussing a military strike against Yemen’s Houthis earlier this month has been a main topic of conversation on The View this week after The Atlantic ...

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has accepted for review the biologics license application for depemokimab in two indications - for asthma with type 2 ...